-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-07-15
Values as of: 2019-07-15
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Gavekal Knowledge Leaders Developed World Index (the "Developed World Index" or the "index"). The fund will normally invest at least 80% of its total assets in securities of the index. The index is designed to measure the performance of issuers in developed markets countries that are considered to be "Knowledge Leaders," as defined and determined by the index provider, based on a proprietary selection model developed by the index provider and incorporated into the index methodology. The fund is non-diversified.
Company Website : www.gavekalfunds.com
Currency: USD
Country : USA
Inception Date: 07/07/2015
Primary Benchmark: Knowledge Leaders Dev World USD
Primary Index: MSCI ACWI Ex USA NR USD
Gross Expense Ratio: 0.75%
Management Expense Ratio: 0.75 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| APH | Amphenol Corporation | 1.58 % |
| BGNE | BeiGene Ltd | 1.38 % |
| GSK | GlaxoSmithKline PLC ADR | 1.34 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| SOJE | SOJE | 0.00 % |
+0.08 (+0.40%) |
USD 65.72B |
| JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
+0.06 (+0.11%) |
USD 32.43B |
| DTB | DTB | 0.00 % |
-0.10 (-0.49%) |
USD 26.58B |
| DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
+0.01 (+0.03%) |
USD 26.00B |
| GBTC | Grayscale Bitcoin Trust (BTC) | 0.00 % |
-2.31 (-3.90%) |
USD 23.75B |
| JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
N/A |
USD 22.73B |
| SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.01 (+0.01%) |
USD 19.79B |
| AVUV | Avantis® U.S. Small Cap Value.. | 0.00 % |
-0.17 (-0.19%) |
USD 10.49B |
| DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
+0.01 (+0.03%) |
USD 10.15B |
| DFAT | Dimensional U.S. Targeted Valu.. | 0.00 % |
-0.03 (-0.06%) |
USD 9.40B |
N/A
| Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 15.52% | 64% | D | 58% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | F | ||
| Total Return | 15.52% | 60% | D- | 53% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -2.02% | 38% | F | 45% | F | ||
| Dividend Return | 0.84% | 18% | F | 13% | F | ||
| Total Return | -1.18% | 34% | F | 41% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | F | ||
| Total Return | N/A | N/A | N/A | N/A | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 7.72% | 92% | A | 61% | D- | ||
| Dividend Return | 8.22% | 92% | A | 58% | F | ||
| Total Return | 0.50% | 13% | F | 13% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 10.53% | 40% | F | 85% | B | ||
| Risk Adjusted Return | 78.01% | 92% | A | 87% | B+ | ||
| Market Capitalization | 5.27M | 53% | F | 25% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
